Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

19 results about "Zymosan" patented technology

Zymosan is a glucan with repeating glucose units connected by β-1,3-glycosidic linkages. It binds to TLR 2 and Dectin-1 (CLEC7A). Zymosan is a ligand found on the surface of fungi, like yeast. Zymosan is prepared from yeast cell wall and consists of protein-carbohydrate complexes. It is used to induce experimental sterile inflammation. In macrophages, zymosan-induced responses include the induction of proinflammatory cytokines, arachidonate mobilization, protein phosphorylation, and inositol phosphate formation. Zymosan A also raises cyclin D2 levels suggesting a role for the latter in macrophage activation besides proliferation. It potentiates acute liver damage after galactosamine injection suggesting that certain types of nonparenchymal cells other than Kupffer cells are involved in zymosan action.

Method for differentiating induced pluripotent stem cells into macrophages

PendingCN119662546Aavoid moral controversyHigh differentiation efficiencyBlood/immune system cellsForeign genetic material cellsCell differentationMonocyte
The invention discloses a method for differentiating induced pluripotent stem cells into macrophages. The method comprises the following steps: S1, inducing pluripotent stem cells to form embryoid bodies; s2, differentiating the embryoid body into a monocyte with CD14 expression; s3, the mononuclear cells are differentiated into macrophages with CD14 / CD11b expression; and S4, polarizing the macrophages into M1 type macrophages and / or M2 type macrophages. According to the method for differentiating the induced pluripotent stem cells into the macrophages, the cells can be effectively induced to differentiate towards the macrophages, the induced pluripotent stem cells are subjected to directional differentiation culture in a short time to obtain the macrophages, and the generated macrophages express CD14 and CD11b and have remarkable phagocytic activity on yeast glycan. The method is of great significance to large-scale production of macrophages.
Owner:SHANDONG YINFENG LIFE SCIENCE RESEARCH INSTITUTE +1

Preparation method of yeast beta-glucan

PendingCN120309757ABiotechnologyFreeze-drying
The invention discloses a yeast beta-glucan preparation method based on high pressure-microjet homogenization treatment, and belongs to the technical field of zymosan extraction. The method comprises the following steps: carrying out high pressure-microjet homogenization pretreatment on active dry yeast, then carrying out autolysis treatment, then extracting beta-glucan by an acid-alkali method, and finally carrying out freeze drying to obtain a high-purity product. The core of the method is that the yeast cell walls are subjected to physical wall breaking by adopting a high pressure-microjet homogenization technology, and the extraction rate and the purity of the beta-glucan are remarkably improved by combining with an optimized acid-alkali treatment process. Compared with a traditional enzymolysis method, the method has the advantages that damage of exogenous enzyme to the beta-glucan structure is avoided, the purity of the obtained product reaches 84% or above, the content of protein impurities is lower than 0.2%, a new way is provided for efficient utilization of yeast cell wall resources, and the method is suitable for the fields of food, medicine and health care products.
Owner:HUAZHONG AGRI UNIV

Extracellular vesicles isolated from stem cells, and uses thereof

The present invention provides extracellular vesicles isolated from stem cells treated with zymosan, Poly LC, and monophosphoryl lipid A (MPLA), their use for treatment of cancer, and a method for preparing the same. The extracellular vesicles according to the present invention contain various miRNAs and cytokines related to anticancer effects, and have tumor growth inhibitory effects. In addition, since the extracellular vesicles exhibit a synergistic effect in cancer treatment when administered in combination with an immune checkpoint inhibitor, a pharmaceutical composition for cancer treatment containing the extracellular vesicles as an active ingredient is highly likely to be effectively useful in cancer treatment by increasing immune activity in the body.
Owner:INEXOPLAT INC

Composition for improving immunity of human body and application thereof

The invention relates to a composition for improving the immunity of a human body and application of the composition, and relates to the technical field of medicines and health care products. , 50-80 parts of rabdosia serra, 15-35 parts of burdock root, 5-10 parts of zymosan and 10-20 parts of clinacanthus nutans. The composition provided by the invention takes rabdosia lingua as a core component and is matched with a proper amount of burdock root, clinacanthus nutans and the like, and all the components cooperate with one another, so that the composition has a remarkable effect of improving immunity. In addition, the selected raw materials are derived from the idea of homology of medicine and food, so that the safety and acceptability of the composition are ensured. Due to the characteristic, the compound is not only suitable for developing treatment medicines for specific people with low immunity, but also widely suitable for preparing various health-care products, such as dietary supplements and functional foods, so that the diversified requirements of different consumer groups on healthy life are met, and the compound has a wide application range.
Owner:李德海

Cancer cytotoxic exosome formulations and methods for use in treating cancer

Compositions and methods for treating cancer, particularly leukemia, using a cytotoxic composition comprising monocytes activated by β-glucan. The monocytes are preferably incubated with the β-glucan and then processed to extract particles, such as microvesicles and exosomes from the treated monocytes to produce the cytotoxic composition. Preferably the cytotoxic composition comprises at least 50% exosomes having a size of 150 nm or less that are activated with β-glucan. Zymosan is the preferred β-glucan. The cytotoxic composition has an apoptosis effect. When a subject having cancer is treated according to preferred embodiments, the cytotoxic composition preferably induces a cytokine response in the subject's immune system. The combination of the cytotoxic composition and cytokine response are synergistic.
Owner:JJR&D LLC

Gel product

The invention provides a gel product which comprises a gel agent and zymosan, and the zymosan is selected from yeast beta-glucan. The gel product provided by the invention comprises the yeast beta-glucan, so that the chewiness, the elasticity and the hardness of the soft sweet product can be remarkably improved, the viscosity is reduced, the texture property of the soft sweet is improved, and the mouth feel is improved; meanwhile, the structural stability of jelly products can be improved, the jelly products are not prone to being dispersed and broken under the action of external force, the adhesiveness is reduced, and the texture and taste are improved. The yeast beta-glucan is added into the gel product, so that nutrient substances in the product can be enriched, and zymosan has the effect of improving body immunity and has a good prevention effect on upper respiratory tract infection. The preparation method has the advantages of simple operation, no special requirement, no influence on flavor, and high application value.
Owner:ANGEL YEAST CO LTD +1

Preparation method of tea-fragrance yellow rice wine

The invention discloses a preparation method of tea-aroma yellow rice wine, and belongs to the technical field of wine brewing. The method comprises the following steps: respectively crushing white hyacinth bean flower, fructus piperis longi and tea leaves; glutinous rice and lactic acid bacteria are added into water for rice soaking; steaming the rice, cooling the glutinous rice to 50 DEG C, adding the white hyacinth bean flower powder, and continuously cooling to 35 DEG C; putting materials into a vat, namely uniformly stirring and mixing water, a white hyacinth bean flower-rice mixture, wheat koji, distiller's yeast and cellulase; performing primary fermentation after feeding, during the primary fermentation period, performing primary raking 8-12h after primary fermentation, then performing timed raking, performing primary fermentation for four times, and adding zymosan for fermentation during third raking; cooling the fermented mash after pre-fermentation, performing post-fermentation, and adding tea powder and fructus piperis longi powder in stages during the post-fermentation period; and after post-fermentation, squeezing, centrifuging and sterilizing the fermentation liquor to obtain the tea-aroma yellow wine. The yellow rice wine disclosed by the invention is sweet and mellow in vinosity, pleasant in fragrance and good in mouth feel, and has tea fragrance, and the bioavailability and flavor quality of theaflavin in the tea-fragrance yellow rice wine are remarkably improved.
Owner:SHAOXING COLLABORATIVE INTELLIGENT MFG PROMOTION CENT +2

Brewing method of low-sweetness flat peach wine

The brewing method comprises the following steps: (1) removing impurities from flat peaches, crushing the flat peaches, putting the flat peaches into a tank, adjusting components, adding SO2 and pectinase, soaking, and extracting clear juice to obtain normal flat peach juice; (2) activating saccharomyces cerevisiae in a water bath to obtain a saccharomyces cerevisiae activating solution; (3) adding the saccharomyces cerevisiae activating solution into the normal juice, and fermenting at constant temperature; (4) when the specific gravity of the fermentation liquor is reduced to 1.050-1.055, adding zymosan; (5) when the specific gravity of the fermentation liquor is reduced to 1.035-1.038, rapidly cooling to obtain low-degree fermentation liquor; (6) standing the low-degree fermentation liquor at a constant temperature to obtain low-degree clear juice; (7) centrifuging and filtering the low-alcohol clear juice to obtain low-alcohol wine juice; and (8) adding SO2 into the low-alcohol wine juice, and filling to obtain the low-alcohol sweet flat peach wine. The raw materials are easy to obtain, the process is simple, consumer groups are wide, industrial production is easy, and good social and economic benefits are achieved.
Owner:SHIHEZI UNIVERSITY

Cancer Cytotoxic Exosome Formulations and Methods for Use in Treating Cancer

Compositions and methods for treating cancer, particularly leukemia, using a cytotoxic composition comprising monocytes activated by-glucan. The monocytes are preferably incubated with the β-glucan and then processed to extract particles, such as microvesicles and exosomes from the treated monocytes to produce the cytotoxic composition. Preferably the cytotoxic composition comprises at least 50% exosomes having a size of 150 nm or less that are activated with β-glucan. Zymosan is the preferred β-glucan. The cytotoxic composition has an apoptosis effect. When a subject having cancer is treated according to preferred embodiments, the cytotoxic composition preferably induces a cytokine response in the subject's immune system. The combination of the cytotoxic composition and cytokine response are synergistic.
Owner:JJR&D LLC

Detection method of traditional Chinese medicine composition for repairing kidney injury and traditional Chinese medicine composition

The invention relates to the technical field of quality detection of traditional Chinese medicine, and particularly discloses a detection method of a traditional Chinese medicine composition for repairing kidney injury and the traditional Chinese medicine composition.The traditional Chinese medicine composition is prepared by matching poria cocos, astragalus membranaceus, American ginseng and cordyceps sobolifera water extracts according to a specific proportion and being supplemented with zymosan and water-soluble vitamin E. According to the detection method, a high-sensitivity CMOS image sensor is adopted to collect a two-dimensional optical image when components in an HPLC system flow out, and the visibility of a low-concentration signal is improved by combining local contrast enhancement, frequency domain filtering and RO I segmentation; an overlapped peak region is identified through a customized lightweight convolutional neural network model, and the identification precision is improved by fusing multi-scale features, an attention mechanism and a knowledge distillation strategy; constructing an image texture and ultraviolet spectrum multi-modal fusion analysis matrix, and combining principal component analysis and component specificity weight factors to realize accurate quantification; and finally outputting the annotated image and the structured quality report.
Owner:YICHUN ZHONGQI JINYU BIOTECHNOLOGY CO LTD

Preparation for preventing and controlling tobacco mosaic disease and application thereof

The present invention belongs to the technical field of prevention and control of tobacco mosaic disease, specifically discloses a preparation and application thereof for preventing and controlling tobacco mosaic disease, and is composed of the following components: yeast polysaccharide 1.5-1.9 g / L, glycyrrhizic acid 1.3-1.7 g / L, sodium cholate 0.7-1.1 g / L, and the remainder is water. Compared with the prior art, the inducer prepared by the present invention, which is composed of three components of yeast polysaccharide, glycyrrhizic acid and sodium cholate, has an inducing effect on tobacco mosaic virus TMV, cucumber mosaic virus CMV and potato Y virus PVY, and has a promoting effect on tobacco growth, and is better than the existing plant immunity inducer Ata Ling. In production, the inducer of the present invention can be applied to the prevention and control of tobacco mosaic disease in the field by spraying, and can also be used for the prevention and control of tobacco seedling virus disease, and its antiviral effect has the characteristics of high efficiency and harmlessness to plants; low cost, convenient operation of tobacco farmers, and strong application prospects.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY +4

Construction method of psoriatic arthritis animal model

The invention belongs to the technical field of construction of disease animal models, and discloses a construction method of a psoriatic arthritis animal model, which adopts zymosan mannan and a complete Freund's adjuvant to jointly induce psoriatic arthritis for modeling. According to the invention, the zymosan mannan and the complete Freund's adjuvant are used for combined induction, so that the typical pathological manifestation of psoriatic arthritis can be stably simulated, and particularly, the model is superior to the existing animal model in the aspect of simultaneously inducing joint inflammation and psoriasis-like skin lesion, and is closer to the pathological characteristics of clinical patients.
Owner:XIANGYA HOSPITAL CENT SOUTH UNIV

Selenium-rich chicken feed and preparation method thereof

The invention provides a selenium-rich chicken feed and a preparation method thereof, and belongs to the technical field of feeds. The selenium-enriched yeast is subjected to wall breaking to obtain yeast organic selenoprotein and zymosan, marigold polysaccharide is extracted from marigold, residues, fish meal, rape seed cakes, corn straw and sodium selenite are mixed and fermented, bacterial liquid, fermented organic selenoprotein and a fermentation product are obtained through separation, the bacterial liquid is embedded to obtain embedded particles, and then the selenium-enriched yeast is prepared. And reacting the yeast organic selenoprotein and the fermentation organic selenoprotein with taurine, chelating Fe and Zn ions to prepare Zn / Fe chelated selenoprotein, and mixing the Zn / Fe chelated selenoprotein with the fermentation product and the embedded particles to prepare the selenium-rich chicken feed. The selenium-rich chicken feed prepared by the preparation method disclosed by the invention contains rich organic selenium which is easy to biologically utilize, also contains rich trace elements such as Zn and Fe, can effectively enhance the resistance of poultry to viruses, reduce the case fatality rate of the poultry, also can obviously improve the egg yield, improve the egg quality, improve the palatability and prolong the storage time, and is relatively low in cost and good in applicability.
Owner:MAIDAN (GUANGZHOU) AGRICULTURAL FOOD CO LTD

Cancer cytotoxic exosome formulations and methods for use in the treatment of cancer

The present invention relates to compositions and methods for treating cancer, particularly leukemia, using a cytotoxic composition comprising monocytes activated by β-glucan. The monocytes are preferably incubated with β-glucan and then treated to extract particles, such as microvesicles and exosomes, from the treated monocytes to produce the cytotoxic composition. Preferably, the cytotoxic composition contains at least 50% β-glucan-activated exosomes having a size of 150 nm or less. Zymosan is a preferred β-glucan. The cytotoxic composition has an apoptotic effect. When a subject with cancer is treated according to the preferred embodiment, the cytotoxic composition preferably induces a cytokine response in the subject's immune system. The combination of the cytotoxic composition and the cytokine response is synergistic.
Owner:JJR&D LLC

A composition containing a combination of zymosan and zinc hyaluronate and its use

PendingCN122272628AGood compression effectavoid damageZinc hyaluronateHair follicle
This invention discloses a composition containing myxobin and zinc hyaluronic acid and its application. The present invention combines myxobin and zinc hyaluronic acid in a specific ratio, which, when used alone, has a better effect on reducing DHT damage to hair follicles and also better promotes hair follicle angiogenesis, exhibiting a synergistic effect on hair growth and hair loss prevention.
Owner:BLOOMATURE BIOTECHNOLOGY CO LTD

Extracellular vesicles isolated from stem cells, and uses thereof

The present invention provides extracellular vesicles isolated from stem cells treated with zymosan, Poly I:C, and monophosphoryl lipid A (MPLA), their use for treatment of cancer, and a method for preparing the same. The extracellular vesicles according to the present invention contain various miRNAs and cytokines related to anticancer effects, and have tumor growth inhibitory effects. In addition, since the extracellular vesicles exhibit a synergistic effect in cancer treatment when administered in combination with an immune checkpoint inhibitor, a pharmaceutical composition for cancer treatment containing the extracellular vesicles as an active ingredient is highly likely to be effectively useful in cancer treatment by increasing immune activity in the body.
Owner:INEXOPLAT INC

Yeast protein, composition thereof, preparation method therefor, and use of yeast protein and composition

A composition containing yeast protein, a preparation method therefor, and the use of the yeast protein and the composition. The outer layer of the yeast protein is coated with zymosan; the yeast protein is in the shape of a sphere or an ellipsoid; the yeast protein has a protein content of 70% or more and a zymosan content of 5%-30%, calculated as the weight percentage of a dry base. The yeast protein of the present invention has obviously lower digestibility than that of soybean protein isolate and whey protein in the stomach, causes a stronger satiety after being eaten compared with whey protein, has the characteristic of slow digestion, and is a slow-digesting protein. The yeast protein of the present invention also contains 18 amino acids, including eight essential amino acids and two semi-essential amino acids for the human body, and thus is a complete protein due to the full type of amino acids. The yeast protein can be used as the slow-digesting protein in the preparation of a composition which is intended to be enterally administered to mammals so as to regulate the postprandial amino acid level in the blood plasma.
Owner:ANGEL YEAST CO LTD +1

Yeast proteins, compositions thereof, and methods for their preparation and use

The present invention relates to the medical technical field, specifically to a yeast protein, its composition, and its manufacturing method and use. The yeast protein of the present invention is spherical or elliptical, with the outside wrapped in zymosan, and based on the dry weight percentage, the yeast protein has a protein content of 70% or more and a zymosan content of 5-30%. The yeast protein of the present invention has a gastric digestibility that is obviously lower than soy protein isolate and whey protein, and the postprandial satiety is greater than that of whey protein, and has the characteristic of being slowly digested, so it is a slowly digestible protein. In addition, the yeast protein of the present invention contains 18 kinds of amino acids, including 8 kinds of amino acids essential for the human body and 2 kinds of semi-essential amino acids, and has a complete amino acid variety, so it belongs to a complete protein. As a slowly digestible protein, it can be used in the manufacture of a composition for enterally administering to a mammal to adjust postprandial plasma amino acid levels.
Owner:ANGEL YEAST CO LTD

A zymosan soft capsule shell, a preparation method and application thereof

The present application relates to the field of food or medicine technology, and in particular to a zymopolysaccharide soft capsule shell, a preparation method and application thereof. The shell can effectively improve the stability problems of the soft capsule product, such as adhesion, oil leakage and hardening of the shell, which are prone to occur during the shelf life, and has a more excellent protective effect on the active ingredients of the environment-sensitive content. At the same time, the raw material cost is low, the preparation process is simple, and the shell has a broad application prospect in the fields of food, medicine and cosmetics.
Owner:ANGEL YEAST CO LTD +1